Journal
RADIOTHERAPY AND ONCOLOGY
Volume 98, Issue 1, Pages 34-37Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2010.10.015
Keywords
Head and neck cancer; Intensity modulated radiotherapy; Weekly cisplatin; Patterns of relapse
Ask authors/readers for more resources
Eighty-three patients with oropharyngeal, hypopharyngeal or laryngeal cancer were treated with concomitant cisplatin 40 mg/m(2) once a week during the radiotherapy and IMRT up to a total dose of 70 Gy. The 2-year rate of local control, overall survival and disease specific survival were 84%, 82% and 89%, respectively. The corresponding 5-year Kaplan-Meier estimates were 79%, 69% and 76%. (C) 2010 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 98 (2011) 34-37
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available